학술논문

Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living with Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial
Document Type
Article
Source
In: Clinical Infectious Diseases. (Clinical Infectious Diseases, 15 October 2019, 69(9):1498-1505)
Subject
Language
English
ISSN
15376591
10584838